Advancing primary care with essential peer-reviewed research and insights into CNS disorders
Page 130
More Articles from The Primary Care Companion for DNS Disorders
Article
How the Probability and Potential Clinical Significance of Pharmacokinetically Mediated Drug-Drug Interactions Are Assessed in Drug Development: Desvenlafaxine as an Example
March 19, 2015
How do you avoid drug-drug interactions in your patients who are taking multiple medications? This article explains the process for assessing the risk of a drug causing or being…
Rounds in the General Hospital
Collaboration and Referral Between Internal Medicine and Psychiatry
February 26, 2015
Have you ever had a patient with active medical problems coupled with a problematic psychiatric disorder? If you have, then the following case vignette and discussion should prove useful…
Article
An Analysis of Relapse Rates and Predictors of Relapse in 2 Randomized, Placebo-Controlled Trials of Desvenlafaxine for Major Depressive Disorder
February 26, 2015
In this article by McIntyre and colleagues, relapse rates and predictors of relapse were evaluated in 2 randomized, placebo-controlled trials of desvenlafaxine for major depressive disorder.
